查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1655536

二十碳五烯酸的世界市場

Eicosapentaenoic Acid
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 94 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球二十碳五烯酸市場規模將達到 65 億美元

2024 年全球二十碳五烯酸市場規模估計為 35 億美元，預計 2030 年將達到 65 億美元，2024 年至 2030 年的複合年成長率為 10.9%。營養保健食品和機能性食品應用是報告中分析的細分市場之一，預計複合年成長率為 11.7%，到分析期結束時將達到 49 億美元。在分析期內，寵物和動物食品應用領域預計將以 7.6% 的複合年成長率成長。

美國市場規模估計為 8.95 億美元，中國市場預估年複合成長率為 14.4%

預計 2024 年美國二十碳五烯酸市值將達 8.95 億美元。中國是世界第二大經濟體，預計到 2030 年市場規模將達到 15 億美元，2024-2030 年分析期間的複合年成長率為 14.4%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 7.1% 和 8.8%。在歐洲，預計德國的複合年成長率約為 8.1%。

全球二十碳五烯酸 (EPA) 市場 - 主要趨勢與促進因素摘要

什麼是二十碳五烯酸 (EPA)？

二十碳五烯酸 (EPA) 是Omega-3脂肪酸，主要存在於脂肪魚和某些藻類中。 EPA 是多不飽和脂肪酸，對人體健康起著重要作用，特別是在支持心血管功能、減少發炎和促進大腦健康方面。 EPA 因其抗發炎特性而受到廣泛認可，使其成為管理各種健康狀況（包括心血管疾病、關節炎和精神障礙）的重要營養素。此外，EPA 也被認為有助於合成稱為二十烷酸的生物活性化合物，這有助於調節人體的各種生理過程。

EPA 在營養中的重要性因其眾多的健康益處而凸顯。定期攝取 EPA 可降低三酸甘油酯水平、減少心律不整的風險並降低血壓，從而改善心臟健康。此外，EPA 在心理健康中也發揮著重要作用，攝取足量的這種脂肪酸可能有助於緩解憂鬱症和焦慮的症狀。隨著消費者健康意識的增強，對富含 EPA 的食品和補充劑的需求不斷增加，從而推動了 EPA 市場的成長。

EPA 的主要用途是什麼以及它如何滿足營養需求？

EPA 的主要用途是膳食補充劑、機能性食品、藥物和動物營養。在膳食補充劑領域，EPA 通常以魚油膠囊、磷蝦油和藻類油補充劑的形式出售。這些產品的目標客戶是希望增加Omega-3攝取量的消費者，以獲得各種健康益處，包括支持心血管健康和減少發炎。 EPA 補充劑的受歡迎程度正在迅速提高，尤其是在注重健康的人和有特定健康問題的人中，導致此類產品的市場不斷成長。

在機能性食品領域，EPA 擴大被加入到各種食品中，包括乳製品、食品和飲料產品以及點心棒。製造商已經意識到具有附加營養價值的健康產品的潛在市場。透過在日常食品中強化 EPA，品牌可以滿足消費者尋求在飲食中添加有益的Omega-3脂肪酸的便捷方式的需求。隨著尋求改善整體健康狀況的消費者對健康機能性食品的需求不斷成長，這一趨勢尤其重要。

EPA 在製藥業也受到關注，其治療應用正在受到考慮。目前正在進行調查，以評估 EPA 在治療各種醫療狀況（包括心血管、發炎和精神疾病）方面的有效性。隨著新的臨床研究的進展，支持 EPA 健康效用的證據將會增加，並可能開發出含有這種重要脂肪酸的新型藥物配方。

此外，在動物營養領域，EPA 在寵物食品和養殖魚類中的應用正在不斷擴大。在寵物營養方面，EPA 現在被添加到狗糧和貓糧中，以支持關節健康、皮膚狀況和整體健康。高階寵物食品日益流行，注重健康益處和高品質原料，這推動了對強化 EPA 等Omega-3脂肪酸的產品的需求。在水產養殖中，EPA 對於養殖魚類的生長和健康至關重要，因為它可以提高飼料品質並改善魚類的健康和生長率。全球對永續養殖魚貝類的需求不斷增加，進一步推動了 EPA 在水產養殖飼料中的使用。

技術進步如何影響 EPA 市場？

技術進步透過改進生產方法、萃取流程和產品配方對 EPA 市場產生了重大影響。一個顯著的發展是提取技術的創新，它提高了天然 EPA 的產量和品質。超臨界流體萃取和冷壓等先進方法使製造商能夠獲得高純度的 EPA 油，同時保留其有益特性。這些萃取技術不僅提高了 EPA 的生產效率，而且還減少了傳統萃取方法對環境的影響。

此外，基於藻類的 EPA 的興起正在徹底改變市場。隨著消費者對永續性和道德採購的意識不斷增強，以藻類為基礎的 EPA 產品作為魚類來源的可行替代品越來越受到支持。藻類油富含 EPA 和二十二碳六烯酸 (DHA)，是一種植物來源選擇，對素食主義者、純素食主義者和有環保意識的消費者俱有吸引力。高效藻類培養和提取技術的開發正在支持該行業的發展，擴大市場上富含 EPA 的產品的供應。

產品配方的進步也提高了 EPA 補充劑的有效性和生物利用度。乳化和封裝技術的創新使得人們能夠製造出更容易被人體吸收、具有穩定、高生物利用度的 EPA 產品。這樣的配方可以提高 EPA 補充劑的整體有效性並提高消費者的滿意度。此外，為了滿足消費者對整體健康解決方案的偏好，結合其他有益成分（如 EPA 和 DHA、抗氧化劑和維生素）的補充劑配方變得越來越普遍。

此外，數位技術和資料分析有助於提高 EPA 市場消費者參與度和產品開發。公司擴大使用消費者反饋和市場研究資料來更好地了解消費者偏好並相應地客製化他們的產品。這種資料主導的方法正在幫助製造商制定有針對性的行銷策略和創新的 EPA 產品，以滿足消費者不斷變化的需求。

最後，對 EPA 健康益處的持續研究正在揭示新的潛在用途和治療應用。隨著對 EPA 在管理各種健康狀況方面的作用的科學研究不斷深入，其用途可能會不斷擴大。人們對Omega-3脂肪酸重要性的認知不斷提高，且越來越多的證據支持其對健康效用，預計將推動消費者和臨床環境對富含 EPA 產品的需求。

推動 EPA 市場成長的因素有哪些？

EPA 市場的成長受到多種關鍵因素的推動，例如消費者對Omega-3脂肪酸健康益處的認知不斷提高、對膳食補充劑的需求不斷增加以及機能性食品領域的不斷擴大。一個主要促進因素是人們越來越意識到 EPA 在支持心血管健康、減少發炎和促進大腦功能方面的作用。隨著消費者的健康意識增強並採取更積極的措施來改善健康，對 EPA 補充劑和強化產品的需求正在上升。

與生活方式相關的健康狀況（包括肥胖、心臟病和精神疾病）的日益普遍，進一步推動了對 EPA 的需求。隨著消費者尋求預防性保健措施， Omega-3補充劑，尤其是 EPA，擴大被視為支持整體健康的有益方法。這一趨勢在老齡化社會尤其明顯，人們正在尋求解決方案來維持認知功能並解決慢性健康問題。

機能性食品市場的擴大也是促進EPA市場成長的關鍵因素。消費者越來越尋求能夠提供額外健康益處的食品，從而導致對 EPA 強化產品的需求增加。製造商透過在各種食品中添加 EPA 來滿足這一需求，包括乳製品、零嘴零食以及食品和飲料產品。為消費者提供適合他們忙碌生活方式的健康和保健選擇正在推動該行業的成長。

此外，永續植物來源飲食的趨勢也引發了人們對藻類衍生的 EPA 產品的興趣。隨著越來越多的消費者採用素食和純素生活方式，對替代來源的Omega-3脂肪酸的需求也日益成長。藻類油富含 EPA 和 DHA，對於希望在不依賴魚類的情況下增加Omega-3攝入量的消費者來說，它提供了一種永續且合乎道德的選擇。消費者偏好向植物來源產品的轉變可能會繼續對 EPA 市場產生正面影響。

最後，正在進行的針對 EPA 治療應用的研究和臨床研究正在推動市場成長。隨著有關 EPA 在管理某些健康狀況方面具有潛在效用的新證據不斷湧現，醫療保健提供者擴大推薦Omega-3補充劑。越來越多的發現支持在臨床環境中使用 EPA，並有助於 EPA 作為必需脂肪酸的廣泛接受和利用。

總而言之，EPA 市場正在經歷強勁成長，這得益於消費者對 EPA 健康益處的認知不斷提高、對膳食補充劑和機能性食品的需求不斷增加以及永續的植物來源營養趨勢。生產和配方技術的進步，以及對 EPA 治療益處的持續研究，預計將進一步增強 EPA 市場的未來前景。隨著消費者越來越重視健康和保健，對富含 EPA 產品的需求預計將會增加，並影響營養和保健的未來。

部分

應用（營養保健品、機能性食品、寵物和動物飼料、嬰兒奶粉、藥物和其他應用）

受訪公司範例（43家值得關注的公司）

  • BASF Nutrition
  • Croda
  • DSM
  • EPAX
  • GC Rieber Oils
  • KD Pharma
  • Orkla Health
  • Polaris
  • Shandong Yuwang Pharmaceutical
  • Sinomega

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲國家
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP17249

Global Eicosapentaenoic Acid Market to Reach US$6.5 Billion by 2030

The global market for Eicosapentaenoic Acid estimated at US$3.5 Billion in the year 2024, is expected to reach US$6.5 Billion by 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Dietary Supplements & Functional Foods Application, one of the segments analyzed in the report, is expected to record a 11.7% CAGR and reach US$4.9 Billion by the end of the analysis period. Growth in the Pet & Animal Feeds Application segment is estimated at 7.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$895.0 Million While China is Forecast to Grow at 14.4% CAGR

The Eicosapentaenoic Acid market in the U.S. is estimated at US$895.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 14.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.1% and 8.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.1% CAGR.

Global Eicosapentaenoic Acid (EPA) Market – Key Trends & Drivers Summarized

What Is Eicosapentaenoic Acid (EPA), And Why Is It Important in Nutrition and Health?

Eicosapentaenoic acid (EPA) is an omega-3 fatty acid primarily found in fatty fish and certain algae. As a polyunsaturated fatty acid, EPA plays a critical role in human health, particularly in supporting cardiovascular function, reducing inflammation, and promoting brain health. EPA is commonly recognized for its anti-inflammatory properties, making it an important nutrient in the management of various health conditions, including cardiovascular diseases, arthritis, and mental health disorders. Additionally, EPA is known to contribute to the synthesis of bioactive compounds called eicosanoids, which help regulate various physiological processes in the body.

The importance of EPA in nutrition is highlighted by its numerous health benefits. Regular consumption of EPA has been linked to improved heart health by lowering triglyceride levels, reducing the risk of arrhythmias, and decreasing blood pressure. Moreover, EPA plays a significant role in mental health, with studies suggesting that adequate levels of this fatty acid may help alleviate symptoms of depression and anxiety. As consumers become more health-conscious, the demand for EPA-rich foods and supplements is on the rise, driving the growth of the EPA market.

What Are the Main Applications of EPA, And How Do They Cater to Nutritional Needs?

Eicosapentaenoic acid (EPA) has several key applications, primarily in dietary supplements, functional foods, pharmaceuticals, and animal nutrition. In the dietary supplement sector, EPA is commonly available in the form of fish oil capsules, krill oil, and algal oil supplements. These products cater to consumers seeking to enhance their omega-3 intake for various health benefits, such as supporting cardiovascular health and reducing inflammation. The popularity of EPA supplements has surged, particularly among health-conscious individuals and those with specific health concerns, leading to a growing market for these products.

In the functional foods segment, EPA is increasingly being incorporated into a variety of food products, including dairy items, beverages, and snack bars. Manufacturers are recognizing the potential market for health-enhancing products that provide added nutritional value. By fortifying everyday foods with EPA, brands can cater to consumers looking for convenient ways to incorporate beneficial omega-3 fatty acids into their diets. This trend is especially relevant as the demand for healthy, functional foods continues to grow among consumers seeking to improve their overall well-being.

EPA is also gaining attention in the pharmaceutical industry, where it is being explored for its therapeutic applications. Research is ongoing to evaluate the efficacy of EPA in managing various medical conditions, including cardiovascular disease, inflammatory disorders, and mental health issues. As new clinical studies emerge, they contribute to the growing body of evidence supporting the health benefits of EPA, potentially leading to new pharmaceutical formulations that incorporate this important fatty acid.

Additionally, the animal nutrition sector is increasingly utilizing EPA in pet foods and aquaculture. In pet nutrition, EPA is being included in dog and cat food formulations to support joint health, skin condition, and overall well-being. The growing trend of premium pet foods, which emphasize health benefits and high-quality ingredients, is driving demand for products fortified with omega-3 fatty acids like EPA. In aquaculture, EPA is crucial for the growth and health of farmed fish, as it enhances feed quality and improves fish health and growth rates. The rising global demand for sustainably farmed seafood is further promoting the use of EPA in aquaculture feeds.

How Are Technological Advancements Impacting the EPA Market?

Technological advancements are significantly influencing the EPA market by improving production methods, extraction processes, and product formulations. One notable development is the innovation in extraction technologies that enhance the yield and quality of EPA from natural sources. Advanced methods, such as supercritical fluid extraction and cold pressing, enable manufacturers to obtain high-purity EPA oils while preserving their beneficial properties. These extraction techniques not only improve the efficiency of EPA production but also reduce the environmental impact associated with traditional extraction methods.

Moreover, the rise of algae-based sources of EPA is transforming the market landscape. As consumers become more aware of sustainability and ethical sourcing, algae-derived EPA products are gaining traction as a viable alternative to fish-based sources. Algal oil, which is rich in both EPA and docosahexaenoic acid (DHA), provides a plant-based option that appeals to vegetarians, vegans, and environmentally conscious consumers. The development of efficient algal cultivation and extraction technologies is supporting the growth of this segment, expanding the availability of EPA-rich products in the market.

Advancements in product formulation are also enhancing the efficacy and bioavailability of EPA supplements. Innovations in emulsification and encapsulation technologies allow for the creation of more stable and bioavailable EPA products that are easier for the body to absorb. These formulations can improve the overall effectiveness of EPA supplements and enhance consumer satisfaction. Additionally, the combination of EPA with other beneficial ingredients, such as DHA, antioxidants, and vitamins, is becoming increasingly common in supplement formulations, catering to consumer preferences for comprehensive health solutions.

Furthermore, digital technology and data analytics are playing a role in improving consumer engagement and product development within the EPA market. Companies are utilizing consumer feedback and market research data to better understand consumer preferences and tailor their product offerings accordingly. This data-driven approach helps manufacturers create targeted marketing strategies and develop innovative EPA products that meet the evolving needs of consumers.

Finally, ongoing research into the health benefits of EPA is leading to new applications and potential therapeutic uses. As scientific studies continue to explore the role of EPA in managing various health conditions, the market is likely to see an expansion of its applications. Increased awareness of the importance of omega-3 fatty acids, along with growing evidence supporting their health benefits, will likely drive demand for EPA-rich products in both consumer and clinical settings.

What Is Driving the Growth in the EPA Market?

The growth in the EPA market is driven by several key factors, including increasing consumer awareness of the health benefits of omega-3 fatty acids, rising demand for dietary supplements, and the expansion of the functional foods sector. One of the primary drivers is the growing recognition of EPA's role in supporting cardiovascular health, reducing inflammation, and promoting brain function. As consumers become more health-conscious and proactive about their well-being, the demand for EPA supplements and fortified products is on the rise.

The increasing prevalence of lifestyle-related health conditions, such as obesity, heart disease, and mental health disorders, is further fueling the demand for EPA. Consumers are seeking preventive health measures, and omega-3 supplementation, particularly with EPA, is increasingly viewed as a beneficial approach to supporting overall health. This trend is particularly prominent among aging populations who are looking for solutions to maintain cognitive function and manage chronic health issues.

The expansion of the functional foods market is another significant factor contributing to the growth of the EPA market. Consumers are increasingly interested in foods that provide additional health benefits, leading to a rise in demand for EPA-fortified products. Manufacturers are responding to this demand by incorporating EPA into a variety of food items, including dairy products, snacks, and beverages. The ability to offer health-enhancing options that fit into consumers' busy lifestyles is driving the growth of this segment.

Additionally, the trend toward sustainable and plant-based diets is promoting interest in algae-derived EPA products. As more consumers adopt vegetarian and vegan lifestyles, the demand for alternative sources of omega-3 fatty acids is rising. Algal oil, rich in both EPA and DHA, presents a sustainable and ethical option for those seeking to increase their omega-3 intake without relying on fish sources. This shift in consumer preferences toward plant-based solutions is likely to continue influencing the EPA market positively.

Finally, ongoing research and clinical studies investigating the therapeutic applications of EPA are driving market growth. As new evidence emerges regarding the potential benefits of EPA in managing specific health conditions, healthcare providers are increasingly recommending omega-3 supplementation. This growing body of research supports the use of EPA in clinical settings, contributing to the broader acceptance and utilization of this essential fatty acid.

In conclusion, the EPA market is experiencing robust growth driven by increasing consumer awareness of its health benefits, rising demand for dietary supplements and functional foods, and the trend toward sustainable and plant-based nutrition. Technological advancements in production and formulation, coupled with ongoing research into the therapeutic potential of EPA, will further enhance the market's prospects. As consumers prioritize their health and well-being, the demand for EPA-rich products is expected to flourish, shaping the future of nutrition and wellness.

SCOPE OF STUDY:

The report analyzes the Eicosapentaenoic Acid market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • BASF Nutrition
  • Croda
  • DSM
  • EPAX
  • GC Rieber Oils
  • KD Pharma
  • Orkla Health
  • Polaris
  • Shandong Yuwang Pharmaceutical
  • Sinomega

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Eicosapentaenoic Acid - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Omega-3 Fatty Acids in Dietary Supplements Drives Growth of Eicosapentaenoic Acid (EPA) Market
    • Increased Adoption of EPA in Cardiovascular Health Products Expands Addressable Market
    • Surge in Demand for EPA in Functional Foods and Beverages Fuels Market Growth
    • Technological Advancements in EPA Extraction from Fish and Algae Propel Market Expansion
    • Growing Focus on EPA for Anti-Inflammatory and Joint Health Benefits Strengthens Business Case
    • Rising Use of EPA in Cognitive and Brain Health Supplements Sets the Stage for Market Growth
    • Surge in Adoption of EPA in Sports Nutrition and Fitness Products Expands Market Opportunities
    • Growing Demand for EPA in Infant and Maternal Nutrition Expands Addressable Market
    • Rising Focus on EPA for Eye Health and Vision Support Fuels Market Demand
    • Technological Advancements in Microencapsulation of EPA for Enhanced Stability Propel Market Growth
    • Surge in Demand for EPA in Elderly Care and Cognitive Decline Prevention Expands Market Growth
    • Rising Use of EPA in Animal Nutrition Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Eicosapentaenoic Acid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Eicosapentaenoic Acid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Dietary Supplements & Functional Foods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Dietary Supplements & Functional Foods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Dietary Supplements & Functional Foods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Infant Formula by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Infant Formula by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Infant Formula by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Eicosapentaenoic Acid Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Pet & Animal Feeds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Pet & Animal Feeds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Pet & Animal Feeds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: Canada 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Japan Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Japan 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 29: China Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: China Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: China 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Eicosapentaenoic Acid by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Europe 15-Year Perspective for Eicosapentaenoic Acid by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 35: Europe Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Europe Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Europe 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 38: France Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: France Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: France 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 41: Germany Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Germany Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Germany 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Italy Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Italy 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 47: UK Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: UK Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: UK 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 50: Spain Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Spain Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Spain 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 53: Russia Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Russia Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Russia 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Rest of Europe Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Rest of Europe 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 60: Asia-Pacific Historic Review for Eicosapentaenoic Acid by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Asia-Pacific 15-Year Perspective for Eicosapentaenoic Acid by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Asia-Pacific 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 65: Australia Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Australia Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Australia 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 68: India Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: India Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: India 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 71: South Korea Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: South Korea Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: South Korea 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 74: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Rest of Asia-Pacific Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Rest of Asia-Pacific 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 77: Latin America Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 78: Latin America Historic Review for Eicosapentaenoic Acid by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Latin America 15-Year Perspective for Eicosapentaenoic Acid by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 80: Latin America Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Latin America Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Latin America 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 83: Argentina Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Argentina Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Argentina 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 86: Brazil Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Brazil Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Brazil 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 89: Mexico Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Mexico Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Mexico 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 92: Rest of Latin America Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Latin America Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Latin America 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 95: Middle East Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Middle East Historic Review for Eicosapentaenoic Acid by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Middle East 15-Year Perspective for Eicosapentaenoic Acid by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 98: Middle East Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Middle East Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Middle East 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 101: Iran Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Iran Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Iran 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 104: Israel Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Israel Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Israel 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 107: Saudi Arabia Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Saudi Arabia Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Saudi Arabia 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 110: UAE Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UAE Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UAE 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 113: Rest of Middle East Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Rest of Middle East Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Rest of Middle East 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Eicosapentaenoic Acid Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 116: Africa Recent Past, Current & Future Analysis for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Africa Historic Review for Eicosapentaenoic Acid by Application - Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Africa 15-Year Perspective for Eicosapentaenoic Acid by Application - Percentage Breakdown of Value Sales for Dietary Supplements & Functional Foods, Pet & Animal Feeds, Infant Formula, Pharmaceuticals and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION